Understanding mechanisms of vitiligo development in Smyth line of chickens by transcriptomic microarray analysis of evolving autoimmune lesions by Shi, Fengying et al.
RESEARCH ARTICLE Open Access
Understanding mechanisms of vitiligo
development in Smyth line of chickens by
transcriptomic microarray analysis of evolving
autoimmune lesions
Fengying Shi
1, Byung-Whi Kong
1, Joon Jin Song
2, Jeong Yoon Lee
1, Robert L Dienglewicz
1 and Gisela F Erf
1*
Abstract
Background: The Smyth line (SL) of chicken is an excellent avian model for human autoimmune vitiligo. The
etiology of vitiligo is complicated and far from clear. In order to better understand critical components leading to
vitiligo development, cDNA microarray technology was used to compare gene expression profiles in the target
tissue (the growing feather) of SL chickens at different vitiligo (SLV) states.
Results: Compared to the reference sample, which was from Brown line chickens (the parental control), 395, 522,
524 and 526 out of the 44 k genes were differentially expressed (DE) (P ≤ 0.05) in feather samples collected from
SL chickens that never developed SLV (NV), from SLV chickens prior to SLV onset (EV), during active loss of
pigmentation (AV), and after complete loss of melanocytes (CV). Comparisons of gene expression levels within SL
samples (NV, EV, AV and CV) revealed 206 DE genes, which could be categorized into immune system-,
melanocyte-, stress-, and apoptosis-related genes based on the biological functions of their corresponding proteins.
The autoimmune nature of SLV was supported by predominant presence of immune system related DE genes and
their remarkably elevated expression in AV samples compared to NV, EV and/or CV samples. Melanocyte loss was
confirmed by decreased expression of genes for melanocyte related proteins in AV and CV samples compared to
NV and EV samples. In addition, SLV development was also accompanied by altered expression of genes associated
with disturbed redox status and apoptosis. Ingenuity Pathway Analysis of DE genes provided functional
interpretations involving but not limited to innate and adaptive immune response, oxidative stress and cell death.
Conclusions: The microarray results provided comprehensive information at the transcriptome level supporting the
multifactorial etiology of vitiligo, where together with apparent inflammatory/innate immune activity and oxidative
stress, the adaptive immune response plays a predominant role in melanocyte loss.
Background
Vitiligo is a postnatal hypopigmentary disease character-
ized by appearance of white patches due to loss of func-
tioning pigment producing cells (melanocytes) in affected
skin. Vitiligo renders patients more susceptible to various
forms of skin cancer and has negative psycho-social
effects on life quality of vitiligo patients, especially when
the depigmented skin is present in sun-exposed areas
[1,2]. The etiology of vitiligo is multifaceted, involving
genetic, immune, metabolic and environmental factors
and the loss of melanocytes in affected tissues is generally
considered to result from autoimmune destruction of
melanocytes [3].
The Smyth line (SL) of chicken is an excellent animal
model for human autoimmune vitiligo, for which many
phenotypical and etiological similarities to human vitiligo
have been documented [4-6]. The genetically vitiligo-
susceptible SL chickens [7-9] develop postnatal and spon-
taneous autoimmune loss of feather pigmentation (SLV),
with 80-95% of hatch-mates expressing the disorder dur-
ing early adulthood [5,8]. Etiopathologically, SLV develop-
ment and progression is associated with mononuclear
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any medium, provided the original work is properly cited.leukocyte infiltration into the target tissue [6], melanocyte-
specific humoral [10-12] and cell-mediated immunity
[13-17] and elevated levels of oxidative stress [18]. In addi-
tion, routine vaccination at hatch with live herpesvirus of
turkey against lymphoma-causing Marek’s disease virus
was identified as a dependable environmental factor
related to SLV expression [19]. Taken together, like in
humans, SLV is a multifactorial disease, which underlines
the suitability of the SL chicken as the avian model for
human vitiligo.
Several vitiligo-susceptibility genes have been identified
for human vitiligo using the candidate gene approach, the
genome-wide linkage approach and the gene expression
approach [20]. However, identification of susceptibility
genes in humans was complicated by the tremendous dif-
ference in genetic background among humans [21]. By
contrast, SL chickens are highly inbred [22] and share the
same MHC-haplotype and background genes as the
Brown line (BL) of chicken from which the SL was
derived. Together the vitiligo-expressing SL chicken and
its parental BL control provide an excellent model to
focus research efforts on vitiligo-related aspects and activ-
ities. Additional attributes of the SL chicken model that
make it highly suitable for vitiligo study are the predictably
high incidence of vitiligo expression (80-95%) [5] and the
fact that melanocytes are located in growing feathers [8].
Collection of growing feathers is a minimally invasive pro-
cedure and growing feathers regenerate, providing oppor-
tunity to repeatedly sample and study the spontaneously
evolving lesions in the same individual throughout the nat-
ural process of vitiligo development.
Using the SL chicken vitiligo model, the purpose of this
study was to examine gene-expression associated with
vitiligo development by comparing transcriptomic pro-
files in samples collected from SL chickens that never
developed SLV (NV) and those collected from the same
SLV chickens before vitiligo onset (EV), during active
(AV) and after complete loss of pigmentation (CV). The
results from the current study will further shed light on
the critical events related to vitiligo development in SL
chickens and in humans.
Methods
Animals
Eighteen SL and four MHC (B
101/101)- and age-matched
BL chicks were randomly selected from 15 SL and 4 BL
families. The BL chicken is the parental control from
which the SL chicken was derived. This line continues to
h a v ear a r ei n c i d e n c eo fv i t i l i g o( <2 % ) .O n e - d a yo l d
chicks were vaccinated with live herpesvirus of turkey
(Fort Dodge Animal Health, Fort Dodge, Iowa) to protect
against Marek’s disease. All chicks were kept in one floor
pen at the Arkansas Experiment Station Poultry Farm in
Fayetteville, AR, USA with feed and water provided ad
libitum. The animal use was approved by the University
of Arkansas Institutional Animal Care and Use
Committee.
Feather collection
The living part of growing feathers (feather tip) [6] was
collected twice a week starting from 4 weeks of age until
the chickens were 20 weeks old (young adulthood; nat-
ural endpoint when feather growth is complete). For each
chicken and collection, three feather tips were snap fro-
zen with liquid nitrogen in Tissue-Tek
® O.C.T freezing
medium (Sakura Finetek Inc., Torrance, CA). All samples
were kept at -80°C until use. For each chicken, vitiligo
development was evaluated at each feather collection
based on pigmentation loss in the growing feathers using
a scale of 1 to 5 following previously described criteria
[16].
Feather sample selection for the microarray study
By the end of the 20-week feather collection, 12 of the
SL chickens had developed SLV (SLV chickens) while
the other 6 SL (non-vitiliginous SL chickens) and the 4
BL chickens had not developed vitiligo. To represent
various stages of SLV development (early, active, and
complete vitiligo) feather tips from each of the 12 SLV
chickens were selected as follows for RNA isolation and
down-stream analysis: two collections before (within 1
week) visible vitiligo onset (early vitiligo; EV sample;
vitiligo score 1), two collections during active vitiligo
(AV sample; vitiligo score 2-4; partially depigmented
regenerating feathers were selected), and two collections
at least one week after complete depigmentation (CV
sample; vitiligo score 5). For the 6 non-vitiliginous SL
(NV sample, vitiligo score 1) and the 4 non-vitiliginous
BL control chickens (BL sample), feather tips obtained
at the same age when the selected SLV samples were
collected (age-matched) were chosen for RNA isolation.
RNA isolation and quantification
Feather tips were taken out of O. C. T. blocks and
h o m o g e n i z e db yT i s s u eT e a r o r ™ (Biospec Products,
Inc. Model: 985370-395) at -20°C in lysis buffer pro-
vided by Qiagen RNeasy
® Mini kit (Qiagen Inc., Valen-
cia, CA). Total RNA was isolated from homogenates
following manufacturer’s instruction with on-column
DNA digestion (Qiagen Inc., Valencia, CA). RNA was
eluted in 30 μl RNase-, DNase-free water and stored at
-80°C until use. RNA integrity and concentration were
determined with an Experion™ automated electrophor-
esis system and Experion™ R N AS t d S e n sa n a l y s i sk i t
(Bio-Rad laboratories, Hercules, CA) following manufac-
turer’s instruction.
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For microarray analysis, separate pools of RNA were pre-
pared for NV, EV, AV, CV and BL samples by mixing
equal amounts of RNA from the pre-selected feather tips
of each bird in the respective samples. For this, the 12 viti-
liginous and 6 non-vitiliginous SL chickens were evenly
divided into 3 groups of 4 and 2 birds each, representing
three SLV- and three NV- replications, respectively. For
each SLV group, RNA pools of their individual EV, AV
and CV samples were prepared. Using RNA isolated from
the age-matched feather samples, one RNA pool was
made for each NV group and one RNA pool was made for
the BL control group. The final concentrations of RNA
pools were determined by the Thermo Scientific Nano-
Drop™ 1000 Spectrophotometer (Thermo Scientific,
Wilmington, DE, USA).
Two-color microarray
A two-color labeling microarray system together with
chicken 4 × 44 k Agilent gene expression microarray
slides (array IDs: 251506810338, 251506810339 and
251506810340; Agilent Technologies, Inc., Santa Clara,
CA) was employed to compare global transcriptomic
profiles between NV, EV, AV and CV samples by using
t h eB Ls a m p l ea st h er e f e r e n c e( r e f e r e n c ed e s i g n ) .R N A
pools from SL chickens (NV, EV, AV and CV) were
labeled with Cy5 (fluoresces red) and the BL pool was
labeled with Cy3 (fluoresces green) by incorporating cya-
nine 5- and cyanine 3-CTP, respectively, during cRNA
generation using T7 RNA polymerase. The two-color
microarray workflow from sample amplification and
labeling to hybridization was carried out as previously
described [23]
Microarray data collection and analysis
Raw data were collected and analyzed with a GenePix
4000B scanner and GenePix Pro 6.1 Software (Molecular
Devices, Inc., Sunnyvale, CA), respectively. Background-
corrected red and green intensities for each spot were
used in the subsequent analysis. Locally weighted linear
regression (LOWESS) was employed to normalize the
fluorescent intensities to retain only biological differences
by removing undesirable systemic variations in microarray
experiments. Moderated t-statistic based on the empirical
Bayes method [24] was applied to each gene to identify
differentially expressed genes in NV, EV, AV and CV sam-
ples relative to BL controls. Comparisons between NV,
EV, AV and CV samples (within SL comparisons) were
performed by One-way ANOVA test using JMP Genomics
4 (multiple means comparison) (SAS Institute Inc, Cary,
NC). Genes with P ≤ 0.05 were considered differentially
expressed (DE). Log2 data obtained by gene-expression
analyses were transformed and reported as linear fold
change values in the result section.
Microarray validation with qRT-PCR
Eleven genes were selected for validation by Taqman
®
qRT-PCR using the same RNA samples as in the micro-
array. Primers and probes were designed by Primer
Express 3.0 (Applied Biosystems, Foster City, CA) and all
primer and probe sets are available upon request. RNA
(2 μg) from NV, EV, AV, CV, and BL pools was reverse-
transcribed into cDNA in a 30 μl reaction volume using a
High Capacity cDNA reverse transcription kit without
RNase inhibitor according to the manufacturer’s protocol
(Applied Biosystems, Foster City, CA). The resulting
cDNA was diluted with RNase- and DNase-free water at
a ratio of 1:3. One μlo ft h i sp r o d u c tw a ss u b j e c t e dt o
PCR using Taqman 2X Universal PCR master mix with
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as
the endogenous control gene and the cDNA from the BL
RNA pool as the calibrator. The following PCR condi-
tions were used: 1 cycle at 50°C for 2 minutes, 95°C for
10 minutes, and 45 cycles of denaturation at 95°C for
15 seconds, and annealing/extension at 60°C for 60 sec-
onds. The relative gene expression was determined by
the delta delta Ct (ΔΔCt) method [25].
Bioinformatics
DE genes were analyzed through the use of Ingenuity
Pathways Analysis (IPA, Version 9.0; Ingenuity Sys-
tems
®; http://www.ingenuity.com).
Results
Differentially expressed (DE, P ≤ 0.05) genes in SL
samples (NV, EV, AV and CV) relative to BL control
samples
Relative to the BL sample, 395, 522, 524 and 526 DE
genes were identified for NV, EV, AV and CV samples,
respectively, which gave rise to 151, 213, 212 and 212
DE genes for Ingenuity Pathways Analysis (IPA) after
deletion of genes without information, genes from
cDNA libraries and clones and genes related to hypothe-
tical proteins. The top 10% of up- and down-regulated
DE genes for individual SLV states are summarized in
Table 1.
The magnitude of the fold change of the top 10% up-
regulated genes was lowest in NV samples, intermediate
in EV and CV and highest in AV samples. The three up-
regulated DE genes with the highest expression were
immunoglobulin J chain (IGJ), acidic chitinase (CHIA)
and T cell receptor (TCR) delta in NV; chemokine ligand
13 (CXCL13), guanylate binding protein (GBP)a n dl i p o -
polysaccharide-induced TNF factor (LITAF)i nE V ;
sodium channel alpha subunit, IGJ and CXCL13 in AV;
and, IGJ, POU class 2 associating factor 1 (POU2AF1)
and myeloid antimicrobial peptide 27 in CV. The magni-
tude of the fold change of down-regulated DE genes was
similar in NV, EV, and AV samples, but higher in CV
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a in growing feathers from SL chickens relative to non-vitiliginous parental BL controls
GeneName/Symbol Up-regulated DE genes GeneName/Symbol Down-regulated DE genes
NV
b
IGJ +5.99
c Lipoprotein VSAF -11.51
CHIA +5.29 MMP9 -7.81
similar to TCR delta chain +3.67 similar to GHITM protein -5.02
COBT +3.58 TMEM22 -3.09
RSFR +2.82 HVCN1 -3.00
CCL19 +2.79 HNRPU protein -2.64
similar to CXCL13 +2.72 MMP13 -2.64
GBP +2.69 similar to keratin -2.49
MX +2.64 FMO6 -2.46
similar to MMR (CD206) +2.63 HIST2H3C protein -2.45
similar to MSTP055 +2.61 ASB12 -2.38
similar to T-cell receptor gamma Vg2-Jg2 +2.60 altronate hydrolase -2.35
GZMA +2.60 GOLGB1 -2.34
TMED8 +2.53 RuBisCu -2.27
ISG12-2 +2.50 LEPREL1 -2.21
EV
similar to CXCL13 +16.01 Lipoprotein VSAF -12.05
GBP +12.08 MMP9 -5.15
LITAF +10.08 similar to keratin -5.11
TNFSF13B +9.77 PTH -4.88
similar to sodium channel alpha subunit +8.74 Adenine phosphoribosyltransferase -3.51
CCL19 +8.17 similar to GHITM protein -3.44
GZMA +7.41 HIST2H3C protein -3.15
IL21R +7.41 FMO6 -2.94
C3AR1 +7.15 TAC1 -2.83
CHIA +7.03 KCNE1L -2.82
similar to immune-responsive protein 1 +6.71 SLC22A5 -2.79
ISG12-2 +6.67 GOLGB1 -2.73
Chemokine ah294 +6.43 TMEM22 -2.70
MX +6.17 MMP13 -2.64
TLR15 +6.15 FCGBP -2.46
similar to MD-2 +6.12 HNRPU protein -2.43
IGJ +6.04 Cytochrome b -2.38
Mucolipin 2 +6.03 similar to CLIC3 -2.34
Gp91-phox +5.91 HVCN1 -2.34
similar to IFIT-5 +5.89 Probable G protein-coupled receptor 26 -2.27
IRF1 +5.85 Thrombomucin -2.24
AV
similar to sodium channel alpha subunit +17.96 PTH -11.70
IGJ +17.84 Lipoprotein VSAF -11.50
similar to CXCL13 +17.13 SLC24A5 -7.23
POU2AF1 +16.37 MMP9 -6.02
TNFSF13B +16.01 MMP115 -5.57
LITAF +14.92 similar to GHITM protein -4.57
LECT2 +11.20 Adenine phosphoribosyltransferase -4.38
similar to immune-responsive protein 1 +10.94 similar to keratin -4.13
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carrier family 24 member 5 (SLC24A5), tyrosinase (TYR),
and matrix metalloproteinase 115 (MMP115).
Some of the top 10% DE genes were shared by more
than two SL samples, although their expression-levels
varied. Up-regulated DE genes shared by EV, AV and
CV samples (SLV samples) included LITAF,t u m o r
necrosis factor superfamily (TNFSF) 13B, interleukin 21
receptor (IL21R), complement component 3a receptor 1
(C3AR1) and sodium channel alpha subunit, with higher
expression levels observed in AV than in EV and CV
samples. Down-regulation was noticed in lipoprotein
Table 1 Top 10% DE genes
a in growing feathers from SL chickens relative to non-vitiliginous parental BL controls
(Continued)
IL21R +10.80 CRYAB -3.78
Gp91-phox +10.58 TMEM22 -3.61
Mucolipin 2 +10.58 KCNE1L -3.46
C3AR1 +10.32 Shikimate 5-dehydrogenase -3.39
GBP +10.23 TAC1 -3.16
Myeloid antimicrobial peptide 27 +9.38 FMO6 -2.74
LYZ +8.92 UPK3B -2.62
similar to MD-2 +8.73 MRRF -2.60
similar to regulator of G-protein signaling 1 +8.65 MMP13 -2.60
TLR15 +8.32 similar to ALS2 -2.49
CCL19 +7.72 HIST2H3C protein -2.45
CHIA +7.65 TYR -2.42
C-C chemokine receptor 11 like +7.59 SLC22A5 -2.42
CV
IGJ +20.76 SLC24A5 -17.06
POU2AF1 +18.19 TYR -15.54
Myeloid antimicrobial peptide 27 +13.31 MMP115 -14.01
similar to sodium channel alpha subunit +12.53 Lipoprotein VSAF -12.43
LECT2 +11.91 PTH -11.89
similar to CXCL13 +8.94 MMP9 -6.95
CHIA +7.39 CRYAB -5.09
TNFSF13B +7.10 Shikimate 5-dehydrogenase -4.83
GBP +6.43 similar to GHITM protein -4.28
C-C chemokine receptor 11 like +6.42 similar to keratin -3.39
GAL7 +6.04 TAC1 -3.38
LITAF +5.82 similar to ALS2 -3.17
Cytochrome b +5.30 TMEM22 -2.95
C3AR1 +5.09 HVCN1 -2.90
similar to regulator of G-protein signaling 1 +5.00 MMP13 -2.83
MX +4.96 similar to EPHX1 protein -2.66
LYZ +4.40 VSX1 -2.55
GPR174 +4.21 GOLGB1 -2.54
IL21R +4.11 FMO6 -2.47
similar to MSTP055 +3.99 HIST2H3C -2.46
ISG12-2 +3.91 similar to BTBD7 -2.45
a: DE genes without gene information, from cDNA clones and of hypothetic proteins were deleted. The whole list of DE genes for all SL samples before deletion
is available upon request
b: NV indicates that feather samples were from SL chickens that never developed vitiligo; EV, AV, and CV indicates growing feathers were from SL chickens with
vitiligo (SLV) before, during and after complete loss of pigmentation
c: numbers in the body of the table are fold changes relative to gene expression levels in samples from BL (the parental line) chickens. For comparison purpose,
the data obtained from the microarray analysis for down-regulated genes (< 1) were expressed as fold changes by calculation: the ratio of 1 to the number (e.g.
for DE value of 0.12 the fold change would be 8.3; i.e. 1/0.12). Up- and down-regulated DE genes were indicated by a positive and negative sign, respectively
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growth hormone induced transmembrane protein
(GHITM), transmembrane protein 22 (TMEM22), kera-
tin, flavin-containing monooxygenase 6 (FMO6), and
histone cluster 2H3C (HIST2H3C)i na l lS Ls a m p l e s( N V
and SLV samples), with lipoprotein VSAF exhibiting the
largest decrease in expression. Other down-regulated DE
genes observed in SLV samples were parathyroid hor-
mone (PTH) and tachykinin precursor 1 (TAC1), with
larger decreases in PTH expression in AV and CV sam-
ples than in EV samples. Expression of SLC24A5,
MMP115,a n dTYR, and genes for crystalline alphaB
(CRYAB), Shikimate 5-dehydrogenase and amyotrophic
lateral sclerosis 2 (ALS2) were commonly depressed in
AV and CV samples relative to BL controls.
Within SL comparisons of DE genes in NV, EV, AV and CV
samples
JMP genomics 4 analysis revealed 206 DE genes for within
SL comparisons, which resulted in 88 DE genes after dele-
tion of unknown genes (without information, from cDNA
libraries and clones and related to hypothetical proteins).
The 88 DE genes could be roughly divided into 4 func-
tional groups which were immunity-, melanocyte-, stress-
related and others (Table 2) based on functions of their
corresponding proteins. More than half of the DE genes
were immune system related, including molecules of both
innate and adaptive branches of the immune system with
more DE genes relating to innate than adaptive immune
response activities (Table 2). The group of DE genes
related to stress contained DE genes associated with cellu-
lar stress and apoptosis.
Compared to SLV samples, the majority of DE genes in
NV samples had the lowest expression level except for all
DE genes related to melanocyte functions (MMP115,
TRP1, TYR and SLC24A5, SLC24A2, GRP143, V-ATPase
C2 subunit and Shikimate 5-dehydrogenase). Additionally,
DE genes related to stress (NPY and CRYAB)a n di n t r a /
inter-cellular transport [gap junction protein alpha 5
(GJA5), transmembrane protein 9 (TMEM9) and synapto-
tagmin 12 (SYT12)], exhibited the highest expression in
NV samples (Table 2). For most DE genes, the expression
levels in EV and CV samples were intermediate to their
expression in NV and AV samples. All genes related to
immune system activities had the highest expression levels
in AV compared to NV, EV and CV samples (Table 2).
The expression levels of DE genes in CV samples tended
to be comparable to EV and/or NV samples. Expression of
melanocyte-related DE genes (i.e. MMP115, TYR, TRP1,
SLC24A2, SLC24A5, V-ATPase C2 subunit), however, was
decreased significantly in AV and reached the lowest
expression in CV samples compared to those from NV
and EV samples. DE genes in the others category, e.g.
intra/inter-cellular transport (GJA5 and TMEM9),a l s o
exhibited the lowest expression levels in CV compared to
NV, EV and AV samples (Table 2).
Ingenuity Pathway Analysis (IPA) for SL samples
The three major output components provided by Ingenu-
ity Pathway Analysis (IPA) are function, network and
pathway interpretations (IPA, Version 9.0; Ingenuity Sys-
tems
®; http://www.ingenuity.com). The functional analysis
identifies biological functions and/or diseases that are
most closely related to the data set. Network interpreta-
tions are algorithmically generated by overlying genes
from a data set onto a global molecular network developed
from information contained in Ingenuity’sK n o w l e d g e
Base. Canonical pathway analysis identifies the pathways
from the Ingenuity Pathways Analysis library of canonical
pathways that most significantly fit the data set (IPA, Ver-
sion 9.0; Ingenuity Systems
®; http://www.ingenuity.com)
Functional analysis
IPA analysis provided similar composition and ranking of
functions for all SL samples (Figure 1). Common functions
not only included those related to normal biological func-
tions, such as cellular-function and -development and
lipid metabolism, but also those associated with a variety
of diseases, e.g. immunological disease, neurological dis-
ease, dermatological disease/condition and cancer. Among
them, the inflammatory response was the most significant
(lowest P values which were due to chance alone) func-
tional interpretation and the first function identified for all
SL groups. However, for any particular common function
identified in the IPA analysis of SL samples, the associa-
tions were made with higher confidence (lower P values)
for DE genes in SLV (EV, AV and CV) samples than in
NV samples. Unique functional interpretations of NV DE
genes included digestive system development and function
as well as organismal survival. Based on function analysis
of DE genes identified by within SL comparisons, amino
acid/carbohydrate metabolism, energy production, protein
folding and developmental disorder were uniquely demon-
strated, however with very low confidence.
Network generation
Network output provided number wise more networks for
D Eg e n e si nS L Vs a m p l e st h a nf o rD Eg e n e si nN Vs a m -
ples or DE genes identified by within SL comparison.
Functional analysis of networks demonstrated that func-
tions for the NV samples and the within SL comparison
group were part of the functional networks identified for
DE genes in SLV samples. In addition to shared functions
between all groups, humoral immune response and immu-
nological disease were only present in EV samples, and
cell-mediated immune response was unique to CV sam-
ples. The 1
st network for NV samples was associated with
functions of cellular movement, immune cell trafficking
Shi et al. BMC Immunology 2012, 13:18
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GeneName/Symbol Accession # NV EV AV CV
Immunity-related
Innate immunity-related
similar to MD-2 BX932484 1.56
d 5.47
b 8.02
a 3.47
c
LYZ CR390743 1.40
c 4.70
b 8.64
a 4.22
b
lymphotactin BX930561 0.93
b 2.29
a 2.66
a 2.18
a
Myeloid antimicrobial peptide 27 DQ092352 0.63
b 0.78
b 8.71
a 12.67
a
Estrogen responsive finger protein BX950599 0.95
c 2.80
a 2.94
a 1.91
b
GAL7 AY621309 1.00
b 0.89
b 6.20
a 5.59
a
GBP X92112 2.56
c 11.57
a 9.87
a 6.09
b
Very large inducible GTPase-1 TC195275 0.44
c 2.70
a 1.99
a 0.80
b
IRF8 L39767 1.09
c 1.66
b 2.79
a 2.43
a
IRF1 L39766 1.58
c 5.72
a 5.22
a 2.52
b
TLR15 DQ267901 1.23
c 5.49
a 7.62
a 2.59
b
C3 U16848 0.99
c 1.57
b 2.23
a 0.99
b
C-C chemokine receptor 11 like TC224438 1.51
c 4.49
b 6.96
a 6.00
ab
Chemokine ah294 TC190676 1.51
c 6.08
a 6.84
a 2.78
b
Cytokine L34552 1.19
c 3.74
ab 4.16
a 2.61
b
CXCR4 AF294794 1.45
c 1.99
b 3.86
a 2.06
b
IL15 AF152927 0.91
c 1.31
b 1.96
a 1.26
b
IL18 AY775780 1.14
d 2.22
b 3.74
a 1.68
c
Beta-defensin CO769187 0.96
c 1.12
c 10.25
b 17.27
a
TNFSF13B AJ721035 2.05
c 8.89
b 14.91
a 6.63
b
chemokine (C-C motif) receptor 8 AJ720982 1.38
c 3.40
a 4.07
a 2.39
b
phosphoinositide-3-kinase, regulatory subunit 5 AJ720866 1.19
c 1.76
b 2.68
a 1.57
b
CD200 receptor 1 BX935064 1.65
a 0.71
c 1.27
ab 0.96
b
C3AR1 AJ720748 2.02
c 6.38
ab 9.49
a 4.73
b
MALT1 AJ851524 1.01
c 2.56
b 3.81
a 2.45
b
CD39 CR385269 0.89
c 1.59
b 2.11
a 1.45
b
FKBP1B BU107658 0.73
a 0.39
b 0.21
c 0.27
c
similar to IMMUNE RESPONSIVE PROTEIN 1 AJ720739 1.32
c 6.04
a 10.21
a 3.29
b
hematopoietic cell-specific Lyn substrate 1 AJ719284 0.86
c 2.24
ab 3.36
a 1.95
b
CD83 CR733120 1.71
d 3.71
b 5.59
a 2.73
c
IRF4 AF320331 1.22
b 1.38
b 3.07
a 3.60
a
similar to Cathepsin L BX934408 1.25
c 2.34
b 3.43
a 1.80
b
Adaptive immunity-related
CR2 AJ720954 1.16
c 5.04
b 7.79
a 4.47
b
POU2AF1 AJ720333 1.95
c 4.00
b 14.79
a 16.84
a
BTK AJ719782 0.93
c 2.18
b 3.25
a 2.16
b
Mucolipin 2 TC215961 1.36
d 5.33
b 9.59
a 3.25
c
PIK3AP1 AF315784 1.29
c 2.57
b 4.57
a 2.92
b
CD5 Y12011 0.86
c 2.06
ab 2.61
a 1.69
b
TRAF3-interacting JNK-activating modulator TC210615 1.64
c 3.07
b 4.98
a 2.45
b
SPI1 Y12225 1.24
c 4.08
a 5.23
a 2.22
b
LAT2 BX950412 0.88
c 1.25
b 2.89
a 2.15
a
IL2RG AJ419896 1.56
c 2.54
b 4.22
a 2.46
b
LCP1 AJ719624 1.05
c 1.89
b 2.54
a 1.54
b
CD8 beta chain Z26484 1.31
c 3.52
a 3.24
a 2.11
b
TCR beta chain M81150 1.21
c 2.55
b 3.71
a 2.71
ab
MHCII U76305 1.21
c 2.37
b 3.77
a 1.84
b
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Page 7 of 15Table 2 Comparison of DE genes between SL samples (within SL comparison)* (Continued)
B2M AB178593 0.98
c 1.77
b 2.94
a 1.66
b
TAP2 AJ843262 1.19
c 4.40
a 4.26
a 2.28
b
GZMA AJ544060 2.48
b 6.86
a 6.79
a 2.96
b
Melanocyte-related
TYR AB023291 1.22
a 1.00
a 0.40
b 0.07
c
TRP1 AF003631 1.03
a 1.03
a 0.24
b 0.03
c
MMP115 D88348 0.92
a 0.46
b 0.17
c 0.07
d
SLC24A5 TC191950 0.93
a 0.50
b 0.13
c 0.05
d
SLC24A2 AF177985 1.08
a 0.78
b 0.45
c 0.48
c
GPR143 BX950829 1.16
a 0.74
b 0.26
c 0.11
d
V-ATPase C2 subunit TC218700 0.83
a 0.62
ab 0.50
b 0.12
c
Shikimate 5-dehydrogenase TC216663 0.86
a 0.20
d 0.29
c 0.51
b
Stress-related
NPY M87294 1.03
a 0.13
d 0.41
c 0.94
b
CRYAB U26661 1.14
a 0.18
c 0.24
b 0.56
b
BLVRA BU468223 0.96
c 1.27
c 1.80
b 2.91
a
GSTA1 L15386 1.19
c 0.73
c 2.00
a 1.40
b
Gp91-phox TC214833 1.50
d 3.01
c 10.02
a 5.43
b
CD163 CR406525 1.39
c 2.18
b 3.93
a 1.80
c
neutrophil cytosolic factor 1 AJ719555 0.90
d 2.57
b 4.64
a 1.49
c
Cytochrome b TC220424 1.38
b 5.06
a 6.91
a 5.14
a
Acetyl-CoA carboxylase 2 TC206581 1.08
d 3.58
a 2.28
b 1.59
c
LITAF AB058634 1.41
d 5.48
c 14.05
a 9.29
b
CARD11 AJ851540 1.03
c 2.63
b 4.62
a 2.01
b
Gasdermin 1 AJ721093 0.83
c 2.14
a 2.89
a 1.27
b
TRAF5 AJ720372 1.30
c 2.65
b 4.25
a 2.35
b
PDCD1 CR390246 1.44
d 3.91
a 5.67
a 2.38
c
Others
GJA5 M35043 1.01
a 0.73
b 0.51
c 0.43
c
TMEM9 TC216868 0.91
a 0.70
b 0.51
c 0.32
d
ATP synthase F0 subunit 8 TC213211 1.20
c 3.40
a 3.30
a 2.13
b
Novel Ras family member protein TC196126 1.28
c 2.64
ab 3.31
a 2.23
b
KCNMB1 AF077369 0.83
c 1.78
b 2.80
a 2.51
a
BTN1A1 AY847576 0.81
c 1.79
b 2.53
a 1.84
b
TF AB215094 0.97
d 2.41
b 3.83
a 1.54
c
GPR174 AJ719761 2.04
c 4.02
b 6.58
a 3.92
b
LIMD2 AJ721104 0.93
c 1.62
b 2.31
a 1.54
b
TSPAN15 AJ720604 1.00
c 2.01
b 3.27
a 1.69
b
LOC423781 CR405911 0.86
c 2.42
b 4.26
a 2.37
b
ASAHL BX950518 1.47
c 3.60
b 6.29
a 2.87
b
SYT12 BX936066 0.80
a 0.59
b 0.33
c 0.42
c
AKAP12 BX932296 0.96
a 0.71
b 0.46
c 0.39
c
AGR2 BX934938 0.88
a 0.67
b 0.41
c 0.38
c
similar to Rho-GTPase-activating protein 6 CR407051 1.08
d 2.50
b 3.66
a 1.44
c
FBP2 BU312699 1.06
a 0.63
b 0.46
c 0.37
c
*: NV indicates that growing feather samples were from SL chickens that never developed vitiligo; EV, AV, and CV indicate that growing feather samples were
collected from SL chickens with vitiligo (SLV) within 1 week before SLV onset, during active depigmentation and at least one week after complete loss of
pigmentation, respectively. Normalized microarray data were filtered to include only fluorescence values above 100 and analyzed by JMP genomics 4 to determine
differences in NV, EV, AV and CV gene expression levels. Values in the body of the table were mean expression (n = 3) relative to BL samples, where numbers >1
and < 1 represents up-regulated and down-regulated expression, respectively. Means without a common letter were significantly different at P ≤ 0.05
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Page 8 of 15and cell morphology; for EV samples, functions of inflam-
matory response, antimicrobial response and humoral
immune response; and for AV and CV samples, inflamma-
tory response, cellular growth and proliferation and hema-
tological system development and function, and cellular
development. These number one networks are illustrated
in Figure 2.
Canonical pathway analysis
Pathway composition was similar for DE genes in SL sam-
ples, with higher levels of similarity between DE genes for
SLV samples. For a specific common pathway higher sig-
n i f i c a n c e[ s u g g e s t e db yah i g h e rr a t i o( n u m b e ro fm o l e -
cules from the data set divided by the total number of
molecules in the pathway obtained from the Ingenuity’s
Knowledge Base) and a lower P value] was exhibited for
SLV samples than for NV samples. Pathway analysis of the
D Ed a t a - s e tg e n e r a t e db yw i t h i nS Lc o m p a r i s o nh a d
numerically the most pathways which included all pathway
components for all SL samples. The pathway of communi-
cation between innate and adaptive immune cells was
most significant, constituting the number-one pathway for
a l lS Ls a m p l e sa n dw i t h i nS Lc o m p a r i s o n .
Microarray validation by qRT-PCR
Microarray data were validated by qRT-PCR based on
comparable gene expression levels and similar expression
trends of selected targets throughout SLV development
(Table 3). Fold changes in complement component recep-
tor 2 (CR2) and POU2AF1 from qRT-PCR, however, were
noticeable higher than those from microarray.
Discussion
The Smyth line (SL) of chicken is an excellent avian
model for human autoimmune vitiligo [4-6], which is a
multifactorial disease of complex etiology resulting in
loss of melanocytes in the skin. In the current study, we
took advantage of the unique attributes of the SL chicken
model (outlined in the Introduction) and the power of
gene expression analysis by microarray to investigate the
pathomechanism of vitiligo in SL chickens (SLV). To our
best knowledge, this is the first paper using microarray
analysis to study transcriptomic expression profiles in
evolving vitiligo lesions. Expression levels of genes from
this microarray study were validated based on their com-
parability to those from qRT-PCR (Table 3), which was
suggested to have higher detection sensitivity than micro-
array [26]. While higher expression was observed for CR2
and POU2AF1 by qRT-PCR than with microarray, their
expression trends were the same with both methodolo-
gies, supporting the validity of the microarray study. The
expression difference may be due to the upper fluores-
cent detection limit of the microarray scanner. Differen-
tially expressed (DE) genes identified by microarray
analysis and the interpretations by Ingenuity Pathway
Analysis http://www.ingenuity.com support the multifac-
torial nature of vitiligo. For the sake of simplicity, the dis-
cussion will focus on observations regarding the
involvement of the immune system, melanocyte biology,
redox status, neurology, apoptosis and other physio-
pathological factors identified to play a role in the spon-
taneous development of SLV.
Immune system
The autoinflammatory/autoimmune nature of SLV was
supported by expression profiling (Table 1 and 2) and
IPA functional interpretations of DE genes (e.g. inflam-
matory response and immunological disease) (Figure 1
and 2). DE genes of both T and B cell markers (Table 1
and 2) and functions of humoral and cell-mediated
immune response (Figure 1 and 2) in the current study
are in line with previous studies demonstrating involve-
ment of both types of immune responses in melanocyte
loss in the etiology of SLV [6,10,12,16]. Furthermore, it
appears that the humoral immune response was particu-
larly important in early SLV development, since DE
g e n e si nE Vs a m p l e sw e r es i g n i f i c a n t l y( 1
st network)
associated with this function (Figure 2). In addition, the
humoral immune response also appeared important in
SLV progression (AV) and complete depigmentation
(CV) as supported by significantly up-regulated DE
genes related to B cell development and/or activation
such as IGJ (immunoglobulin J chain), POU2AF1 (a pro-
tein essential for the B cell response and germinal center
formation), BTK (Bruton’s tyrosine kinase), mucolipin 2
(a target for BTK in B cells), SPI1 (a lymphoid specific
enhancer involved in B cell differentiation and activa-
tion), and PIK3AP1 (B cell activation) in these samples
(Table 1 and 2). On the other hand, DE genes associated
with the cell-mediated immune response were identified
only in CV samples and with lower significance than DE
genes associated with the humoral immune response in
EV samples. A more relevant role of the humoral
immune response in the pathomechanism of SLV is
contradictory to the demonstrated more direct role of
the cell-mediated immune response in this disorder
[6,16]. Confirmation of this finding will definitely impact
future direction of vitiligo research.
Aside from involvement of adaptive immunity in SLV, it
is apparent that innate immunity also plays an important
role in SLV development since the majority of immune-
related DE genes were derived from this branch of the
immune system (Table 1 and 2). Innate immunity has not
received much attention in vitiligo studies in either the SL
animal model or human patients. Elevated expression of
genes for chemokines (e.g. CXCL13, CCL19), pattern
recognition receptors (e.g. MMR, TLR15, MD-2 and
PRAM-1), TNF and type 1 and 2 interferon cytokines (e.g.
Shi et al. BMC Immunology 2012, 13:18
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Page 9 of 15LITAF, TNFSF13B, ISG12-2, ITIF5, IRF1 and IRF8) (Table
1 and 2) suggested both anti-bacterial and anti-viral activ-
ity especially in early and active stages of SLV (EV and
AV). The complement system also appears to participate
in SLV development and progression as supported by sig-
nificantly increased expression of genes for C3, C3AR1
and CR2 in AV samples (Table 1 and 2). Functional analy-
sis of networks by IPA revealed that DE genes identified in
EV and AV samples were significantly associated (1
st and
3
rd network) with the functions of anti-microbial response
and infectious disease, respectively. These observations
suggest a potential role of the innate immune response as
a precipitating and effector factor in the development of
the melanocyte-specific adaptive immune response in
SLV. Initiation of antimicrobial activity in SLV is in agree-
ment with the strong association of live herpesvirus of tur-
key administration at hatch (routine vaccination to protect
SL and BL chickens from Marek’s disease virus) as a reli-
able environmental trigger of SLV expression in vitiligo-
susceptible SL chickens [19]. Additionally, as innate
immunity is also initiated in response to cellular stress, the
observed alterations in melanocyte biology and redox sta-
tus (see below) may also be responsible for activation of
innate immune responses in SLV [27].
Figure 1 Graphical demonstration of associated functions from Ingenuity Pathway Analysis (IPA) of differentially expressed (P ≤ 0.05;
DE) genes for NV, EV, AV, CV relative to BL samples. The functional analysis identifies biological functions and/or diseases that are most
significant to the data set. Molecules from the DE gene dataset that are associated with biological functions and/or diseases in Ingenuity’s
Knowledge Base were considered for the analysis. Right-tailed Fisher’s exact test was used to calculate a P-value determining the probability that
each biological function and/or disease assigned to that data set is due to chance alone. The y-axis displays the functional categories that are
identified in analyses. The x-axis demonstrates the significance which is the value of -log (P). Functions are listed from most significant to least
and the orange vertical line denotes the cutoff for significance (P-value of 0.05). For each analysis, only the top 18 functional categories are
displayed due to large size of the data files.
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Page 10 of 15Figure 2 Network #1 obtained by Ingenuity Pathway Analysis (IPA) of differentially expressed (P ≤ 0.05; DE) genes for NV, EV, AV, CV
relative to BL samples. DE genes from the data sets were overlaid onto a global molecular network developed from information contained in
Ingenuity’s Knowledge Base to algorithmically generate networks that graphically represent relationships between molecules. Molecules are
represented as nodes, and the biological relationship between two nodes is represented as an edge (line). The intensity of the node color
indicates the degree of up- (red) or down- (green) regulation. Nodes are displayed using various shapes that represent the functional class of
the gene product. Edges are displayed with various labels that describe the nature of the relationship between the nodes.
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It was previously shown that intrinsic abnormalities of
melanocytes, the target cell in vitiligo, were present in
SL chickens compared to BL and LBL (vitiligo-resistant,
similar plumage color pattern control) controls [7,28].
In the current study, melanocyte loss appeared to be
preceded by disturbances in melanosome structure,
intracellular molecule transport and tyrosine synthesis
as demonstrated by decreased expression of MMP115,
SLC24A2, SLC24A5, GPR143, and Shikimate 5-dehydro-
genase in EV samples (Table 1). Dysfunction and loss of
melanogenesis became obvious in AV and CV samples,
as suggested by significantly decreased gene expression
in TYR and TRP1 in these samples compared to NV
and EV samples (Table 2). This finding is consistent
with findings in human studies, where down-regulation
of TYR and TRP1 was revealed in lesional skin com-
pared to non-lesional skin of vitiligo patients and skin
from healthy donors [29-31].
Redox status
Oxidative stress was previously demonstrated in vitiligo
patients [32-35] and in SLV chickens [18]. In humans,
oxidative stress involvement was further supported by
the repigmenting effect of antioxidant substances in the
treatment of vitiligo lesions [36-38]. In line with findings
from these studies, there were DE genes for all SL sam-
ples and those generated from within SL comparison
identified by IPA to be associated with the function of
free radical scavenging (including functional annotation
of synthesis/production of oxidative species). NV sam-
ples had similar DE gene expression for both pro- and
anti-oxidative proteins relative to the BL control sam-
ples whose expression was considered as the value of 1
(Table 2). Up-regulation of these DE genes in SLV sam-
ples, especially AV samples (Table 2) suggested associa-
tion of SLV development with disturbances in redox
status. Among these, remarkably elevated expression
was noticed for Gp91-phox and cytochrome b (Table 2),
suggesting an important role of these proteins in chan-
ging the redox status in SLV chickens. Gp91-phox is a
subunit of NADPH oxidase containing the heme binding
site important in reactive oxygen species (ROS) produc-
tion [39]. The source of NADPH-dependent ROS pro-
duction in vitiligo development is not clear, however,
after activation, phagocytes and B cells are capable of
NAPDH-dependent release of ROS [40,41]. With more
DE genes related to B cell than phagocyte development
and/or activation in the current study (Table 1 and 2)
and the greater B cell than macrophage infiltration in
feather tissues at all vitiligo states reported by Shi and
Erf [6], it is likely that B cells could be an important
source of ROS in SLV development. As revealed by IPA,
decreased transmembrane potential of mitochondria and
the mitochondrial membrane was one of the many func-
tional interpretations of DE genes in EV, AV and CV
samples suggesting mitochondrial involvement in ROS
production. Elevated expression of cytochrome b and
acetyl-CoA carboxylase 2, which is important in fatty
acid oxidation, in EV, AV and CV compared to NV
samples points to mitochondrial production of ROS
probably due to premature electron leakage of oxygen at
the location of cytochrome b in the electron transport
chain [42].
Table 3 Relative expression of DE genes in SL samples
a from microarray vs. qRT-PCR analysis
b
NV EV AV CV
GeneSymbol Accession # Micro-array RT-PCR Micro-array RT-PCR Micro-array RT-PCR Micro-array RT-PCR
IRF1 L39766 1.58 1.73 5.72 7.32 5.22 8.08 2.52 3.46
TLR15 DQ267901 1.23 1.47 5.49 12.54 7.62 18.41 2.59 3.66
CR2 AJ720954 0.21 9.88 2.33 54.92 2.96 174.26 2.16 62.87
POU2AF1 AJ720333 0.96 3.63 2 18.32 3.89 61.51 4.07 67.04
B2M AB178593 0.98 1.28 1.77 3.46 2.94 4.82 1.66 3.01
CRYAB U26661 1.14 1.41 0.18 0.53 0.24 0.19 0.56 0.09
NPY M87294 1.03 0.79 0.13 0.49 0.41 0.1 0.94 0.004
TRAF5 AJ720372 0.37 1.44 1.4 4.61 2.09 6.39 1.24 3.99
LITAF AB058634 1.41 1.42 5.48 13.21 14.05 21.88 9.29 11.23
TYR AB023291 1.22 1.12 1 0.8 0.4 0.26 0.07 0.001
TRP1 AF003631 1.03 1.25 1.03 0.51 0.24 0.04 0.03 0
a, SL samples included NV, EV, AV and CV samples which were from SL chickens that never developed vitiligo; from vitiliginous SL chickens within 1 week before
SLV onset, during active depigmentation and at least one week after complete loss of pigmentation, respectively
b, Gene expression in NV, EV, AV and CV was presented by fold changes relative to expression in BL samples in microarray and in qRT-PCR, where fold-change
was determined by the delta delta Ct method. The same RNA pools for NV, EV, AV, CV and BL samples used in the microarray study were reverse transcribed to
cDNA, which was subjected to qPCR with GAPDH as the endogenous control gene and cDNA from BL sample as the calibrator. All values are fold change means
of three replications analyzed by JMP Genomics 4 for microarray and SYSTAT for qRT-PCR data
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Neural involvement in vitiligo was supported by appear-
ance of localized vitiligo lesions following nerve damage
in affected skin and by morphological changes in term-
inal cutaneous nerves in vitiligo patients [43]. In line
with observations in humans, neurological disease was
presented as one of the functional interpretations by
IPA for DE genes in SL samples and DE genes identified
based on within SL comparisons in the current study. In
addition, expression of TAC1 (gene for neurotransmitter
substance P, neurokinin A, neuropeptide K and neuro-
peptide gamma), KCNE1L (a protein capable of regulat-
ing neurotransmitter release and neuronal excitability),
ALS2 (plays a role in axon and dendrite development)
and NPY (neuropeptide Y) were decreased in EV, AV,
and CV samples compared to NV samples (Table 1 and
2), supporting neural involvement in SLV development.
NPY expression was also investigated in human studies;
the results, however, were not consistent [44,45] and dif-
fered from the decreased expression with SLV progres-
sion in the current study. Other studies revealed an
increased number of nerve growth factor receptor-, cal-
citonin gene-related peptide- and protein gene product
9.5-positive nerve fibers in involved skin from vitiligo
patients compared to healthy controls [45,46]. More-
over, increased serum and urinary levels of catechola-
mines and their relative metabolites were found in
vitiligo patients, especially in early and active stages of
vitiligo, than in controls [47-49]. It was speculated that
a role of catecholamines in vitiligo onset was due to
their potential to undergo oxidation, resulting in forma-
tion of quinones, semiquinone radicals and oxyradicals
[47,49].
Apoptosis
While the mechanism by which melanocytes are
destroyed in vitiligo is still in debate, it has been sug-
gested that they disappear via apoptosis (presumably
initiated by cytotoxic T cells) rather than necrosis [50].
In the current study, significant up-regulation of apopto-
sis-related DE genes, especially in AV compared to NV,
EV and/or CV samples (Table 2), indicated a close rela-
tionship of apoptosis with SLV development. These
apoptosis-related up-regulated DE genes included
GZMA, LITAF (induced by p53 and has been implied in
p53 induced apoptosis), caspase-associated recruitment
domain, member 11 (CARD11, a positive regulator of
cell apoptosis), gasdermin 1 (involved in apoptosis
induction), TNF receptor associated factor 5 (TRAF5)
and programmed cell death 1 (PDCD1)( T a b l e2 ) .I n
addition, participation of apoptosis in SLV etiology was
also supported by the IPA association of functions such
as cell death (Figure 1) and pathways of apoptosis sig-
naling and cytotoxic T cell-mediated apoptosis of target
cells with DE genes in SL samples and DE genes identi-
fied by within SL comparison. These findings are consis-
tent with elevated levels of apoptotic (TUNEL+) cells in
the melanocyte region of growing feathers from vitiligi-
nous SL chickens (particularly during active depigmen-
tation) compared to non-vitiliginous SL, BL and LBL
controls [17]. The mechanism of apoptosis was also
indicated by decreased levels of anti-apoptotic protein
Bcl2 in lesional skin compared to nonlesional skin of
vitiligo patients [51,52].
Others
The decreased expression of t h eg e n ef o rk e r a t i ne s p e -
cially in EV and AV compared to NV samples (Table 1)
may suggest disturbance in keratinocyte function in early
stages of SLV development. Since keratinocytes play
important roles in supporting melanocyte growth and
regulating melanogenesis in melanocytes [53], keratino-
cyte malfunction can have detrimental effects on melano-
cyte functions. Constant and concurrent down-regulation
in matrix metalloproteinase MMP9 and MMP13 in SL
chickens could be due to aberrant keratinocyte function,
based on the observations in human studies that kerati-
nocyte-derived MMP9 was important in repigmentation
by enhancing melanocyte migration [54,55]. Three DE
genes TMEM9, TMEM22 and sorting Nexin 10 may sug-
gest abnormal inter/intracellular molecule/organelle traf-
ficking in SLV chickens. The reason for noticeably
decreased expression in lipoprotein VSAF in SL chickens
compared to BL is not clear due to lack of functional
information on this protein. Significant down-regulation
of parathyroid hormone (PTH)i nE V ,A Va n dC Vc o m -
pared to NV samples may suggest a possible role of PTH
in SLV expression as its biological function is to increase
serum calcium levels and vitamin D synthesis, both of
which are important in melanogenesis.
Conclusions
The multifactorial etiology of autoimmune SLV is sup-
ported by the DE gene profiles from the microarray
study and by their interpretations by IPA. Basically, in
susceptible SL chickens SLV may occur primarily
through melanocyte-specific immune destruction of
aberrant melanocytes under certain pathobiological cir-
cumstances where pre-existing “danger” signals and oxi-
dative stress may act as essential triggers.
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